SCHEMBL20038124

SCHEMBL20038124

Cc1ccc(N(C)C(=O)CN)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.41
AOC3 Q16853 7/20 0.40
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14337547 0.83 NOTUM (0.41) NOTUMHDAC1HDAC6CYP1A2CYP2C19
SCHEMBL20038118 0.82 AOC3 (0.39) NOTUMAOC3GABRPGABRDGABRA1
SCHEMBL20249276 0.80 AOC3 (0.37) NOTUMAOC3HDAC1HDAC6GABRP
SCHEMBL18291288 0.80 AOC3 (0.37) NOTUMAOC3HDAC6GABRPGABRD
SCHEMBL23951955 0.80 SMN1; SMN2 (0.40) AOC3HDAC1HDAC6CYP1A2CYP2E1
SCHEMBL21592981 0.79 ALDH1A1 (0.45) HDAC1HDAC6TSHRSMN1; SMN2
SCHEMBL30937169 0.77 HDAC1 (0.41) NOTUMHDAC1HDAC6CYP1A2CYP2C19
SCHEMBL4107217 0.77 ALDH1A1 (0.46) AOC3KDM4ETSHRSMN1; SMN2
SCHEMBL16454352 0.75 HDAC1 (0.39) NOTUMHDAC1HDAC6CYP1A2CYP2C19
SCHEMBL27316414 0.74 ADRA2A (0.42) HDAC1HDAC6CYP1A2CYP2E1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed